HLTH: A New Era of Patient-Centric Medicine with Shaun Noorian
Compounding pharmacies in a digital-first healthcare landscape is essential for democratizing access to affordable and personalized medications and achieving better outcomes.
In this episode, Shaun Noorian, founder and CEO of Empower Pharmacy, shares insights into how compounding pharmacies are transforming healthcare by providing personalized, cost-effective solutions. Shaun highlights the rising demand for compounded medications in a digital-first healthcare system, emphasizing the shift away from traditional models towards direct, patient-centric approaches. He explains how patients are contacting the providers directly, skipping all the intermediaries that are raising the costs of medicines. Shaun also talks about how Empower Pharmacy innovates to make healthcare more accessible, affordable, and customized to individual needs, ultimately creating a future where patients have more control and access to quality therapies.
Tune in and discover how compounding pharmacies and a patient-centric approach can improve health outcomes faster and more effectively and be the future of health.
Resources
Connect with and follow Shaun Noorian on LinkedIn.
Follow Empower Pharmacy on LinkedIn and explore their website.
About Shaun Noorian
Shaun Noorian is the founder, CEO, and Chairman of Empower Pharmacy, a leader in the compounding pharmaceutical industry. Under Shaun’s leadership, Empower Pharmacy has become the largest compounding pharmacy in the U.S., dedicated to making high-quality, affordable, personalized medications accessible to everyone.
What you'll learn:
Personalized medications can harness the power of compounding to achieve better health outcomes at a lower cost.
Telemedicine and compounding pharmacies enhance healthcare accessibility and transparency.
The traditional retail pharmacy model is shifting toward centralized compounding facilities that distribute medications directly to patients.
Empower Pharmacy’s investments in infrastructure, automation, and scaling are improving patient access to personalized therapies.
